Introducing
Osciflex
Osciflex system imitates nature’s process to prevent deadly blood clots.
Venous thromboembolism (VTE) is a leading cause of complication and death for hospitalized patients. Patients who sustain a VTE have approximately twice the length of stay and total inpatient cost as patients who do not.
Prevention of hospital associated VTE (HA-VTE) is a national priority.
>70% of ALL hospital patients are considered at risk.
There are 300,000-600,000 cases per year in the US, most in hospitals.
Approximately 1 in 5 patients are readmitted within 30 days.
This is the LEADING cause of preventable hospital deaths in the US (~100,000/year).
These clots cost the Healthcare System $7-$10 Billion annually in the U.S.
